Status:
COMPLETED
Raltegravir in the Swiss HIV Cohort Study
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Swiss HIV Cohort Study
Merck Sharp & Dohme LLC
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Brief Summary
Since June 2007, raltegravir has been available in Switzerland within a named patient program for patients who have virologic failure, triple class experience and resistance, and no other treatment op...
Eligibility Criteria
Inclusion
- all patients treated with Raltegravir within the Swiss HIV Cohort Study
Exclusion
- drop out of the Swiss HIV Cohort study
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00904644
Start Date
April 1 2008
End Date
December 1 2011
Last Update
June 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091